AVENIO Trademark

Trademark Overview


On Wednesday, April 13, 2022, a trademark application was filed for AVENIO with the United States Patent and Trademark Office. The USPTO has given the AVENIO trademark a serial number of 97360939. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, May 1, 2024. This trademark is owned by Roche Molecular Systems, Inc.. The AVENIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research in the field of genome sequence analysis and reporting; medical research in the field of genome sequence analysis and reporting; dna screening for scientific research purposes; providing reagent sample testing services for others in the fields of science and scientific research; computer services, namely, cloud hosting provider services for storing, analyzing and sharing biological information; computer services, namely, hosting an interactive web site that allows users to store, analyze and share data in the field of life science; technical support services, namely, infrastructure management services for monitoring, administration and management of cloud computing it and application systems in the field of life science; consulting services in the field of cloud computing in the field of life science; providing temporary use of online non-downloadable software for the custom design and ordering of assays and reagents; design and development of laboratory apparatus, ...
avenio

General Information


Serial Number97360939
Word MarkAVENIO
Filing DateWednesday, April 13, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, May 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 7, 2023

Trademark Statements


Goods and ServicesScientific research in the field of genome sequence analysis and reporting; medical research in the field of genome sequence analysis and reporting; dna screening for scientific research purposes; providing reagent sample testing services for others in the fields of science and scientific research; computer services, namely, cloud hosting provider services for storing, analyzing and sharing biological information; computer services, namely, hosting an interactive web site that allows users to store, analyze and share data in the field of life science; technical support services, namely, infrastructure management services for monitoring, administration and management of cloud computing it and application systems in the field of life science; consulting services in the field of cloud computing in the field of life science; providing temporary use of online non-downloadable software for the custom design and ordering of assays and reagents; design and development of laboratory apparatus, instruments and computer systems for use in analysis of biomolecules; installation and maintenance of computer software and database systems used in the field of analysis of biomolecules; consultancy, information and advisory services in the field of scientific analysis of biomolecules; product development, namely, developing equipment for use in preparing, detecting, analyzing and sequencing nucleic acids and other biological molecules, and automated laboratory equipment and systems, and computer systems for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data to the order and specification of others, all the foregoing in the fields of scientific and clinical research; clinical diagnostic services in preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules from human beings or animals for scientific and medical research purposes; design and development of medical diagnostic apparatus and instruments and computer systems for use in analysis of biomolecules; scientific consulting and research services and clinical laboratory testing services in the fields of amplification, detection, sequencing and analysis of nucleic acids and the preparation of nucleic acid libraries; nucleic acid sequencing services for scientific research purposes; scientific research, namely, computational analysis of nucleic acid sequences and development of computational technologies for the analysis of nucleic acid sequences

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 19, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRoche Molecular Systems, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPleasanton, CA 94588

Party NameRoche Molecular Systems, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPleasanton, CA 94588

Trademark Events


Event DateEvent Description
Saturday, April 16, 2022NEW APPLICATION ENTERED
Tuesday, April 19, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 30, 2023ASSIGNED TO EXAMINER
Monday, January 30, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 7, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 2, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 25, 2023SOU EXTENSION 1 FILED
Wednesday, October 25, 2023SOU EXTENSION 1 GRANTED
Wednesday, October 25, 2023SOU TEAS EXTENSION RECEIVED
Friday, October 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 1, 2024SOU EXTENSION 2 FILED
Wednesday, May 1, 2024SOU EXTENSION 2 GRANTED
Wednesday, May 1, 2024SOU TEAS EXTENSION RECEIVED
Thursday, May 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 10, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 10, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 10, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED